Drug Safety Information for TRACLEER (Bosentan)

Safety-related Labeling Changes for TRACLEER (BOSENTAN) Rx Drug: FDA Link

Adverse Drug Reactions for TRACLEER* (Bosentan)

These charts and graphs are based on reports received through the FDA Adverse Event Reporting System (FAERS) program (see below).

Top 20 Adverse Effects Associated with TRACLEER
(reported in FDA Medwatch/FAERS Reports)

  Side Effect # of FDA Reports
1Death8931
2Dyspnoea*3260
3Pneumonia1579
4Pulmonary arterial hypertension1385
5Aspartate aminotransferase increased1255
6Alanine aminotransferase increased1231
7Condition aggravated1142
8Liver function test abnormal1004
9Oedema peripheral977
10Fatigue927
11Nausea924
12Pulmonary hypertension910
13Fall885
14Dizziness852
15Fluid retention798
16Right ventricular failure770
17Respiratory failure744
18Blood alkaline phosphatase increased742
19Headache735
20Vomiting720

* This side effect also appears in "Top 10 Side Effects of TRACLEER " in the drug's Review Summary based on AskaPatient reviews.

Top 10 Reasons for Taking TRACLEER
(associated with FDA Medwatch/FAERS Reports)

Reason # of FDA Reports
1Pulmonary arterial hypertension61375
2Pulmonary hypertension*16197
3Product used for unknown indication4803
4Skin ulcer1250
5Cor pulmonale chronic1006
6Portopulmonary hypertension223
7Systemic sclerosis195
8Scleroderma174
9Raynaud's phenomenon172
10Digital ulcer164

*Also a top-10 reason in AskaPatient Review Summary.


Types of Adverse Events for TRACLEER

Total Reports Filed with FDA: 96850


Number of FDA Adverse Event Reports by Patient Age for TRACLEER

Total Reports Filed with FDA: 96850*


* Reports for drugs with the same active ingredients have been aggregated in this analysis: Bosentan (Tracleer)

Charts are based on 96850 reports filed with the FDA between 2004 and June 2015.

Adverse Event Reports are submitted to the FDA by pharmaceutical companies (mandatory reporting is required by manufacturers, distributors, or importers), health care providers such as doctors (voluntary reporting), and by patients themselves (voluntary reporting). More Information on FDA MedWatch (FDA Safety Information and Adverse Event Reporting Program)Voluntary reporting takes place under the FDA's MedWatch program, where health care professionals and consumers submit reports to FDA when they find a problem with a drug, medical device, biologic, or other FDA-regulated product. An adverse event is any undesirable experience or extreme side effect associated with the use of a medical product. Adverse events include: death, life threatening event, hospitalization, disability or permanent damage, congenital anomaly or birth defect, medical product use requiring a surgical or other intervention, or other serious medical situation believed to be caused by the drug.

Click to go back to search results and TRACLEER Reviews and Review Summary .

Historical Analytics of FDA Adverse Event Reports Provided by Druginformer.com. FDA Drug Safety Information, including safety-related labeling updates, required post-approval safety studies, risk evaluation management strategies (REMS), alerts, and recalls are compiled by AskaPatient.com from the U.S. Food and Drug Administration.